How many drugs treat Solid malignant tumours?

Drug Landscape tracks 2 marketed treatments for Solid malignant tumours (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/solid-malignant-tumours.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Solid malignant tumours — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Solid malignant tumours (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Solid malignant tumours, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Mozobil	plerixafor	Sanofi	Hematopoietic Stem Cell Mobilizer [EPC]	C-C chemokine receptor type 2		2008-01-01
Mozobil	Mozobil	University of Washington		Stromal cell-derived factor 1, Atypical chemokine receptor 3, C-C chemokine receptor type 2

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Sanofi · 1 drug in Solid malignant tumours
University of Washington · 1 drug in Solid malignant tumours

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Solid malignant tumours:

Cite this brief

Drug Landscape (2026). Solid malignant tumours — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/solid-malignant-tumours. Accessed 2026-06-10.

Solid malignant tumours full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing